Octanoic acid, 4-methyl-, (4S)-
Common Name: |
Octanoic acid, 4-methyl-, (4S)- |
IUPAC Name: |
(4S)-4-methyloctanoic acid |
Molecular Formula: |
C9H18O2 |
SMILES: |
CCCCC(C)CCC(=O)O |
Inchi: |
1S/C9H18O2/c1-3-4-5-8(2)6-7-9(10)11/h8H,3-7H2,1-2H3,(H,10,11)/t8-/m0/s1 |
Inchi Key: |
LEGGANXCVQPIAI-QMMMGPOBSA-N |
Cas No: |
128342-72-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
158.24 |
Mass (g/mol) |
158.131 |
Molar Refractivity |
47.15 |
Net Charge |
-1 |
HBD |
1 |
HBA |
2 |
Rt Bonds |
6 |
Rings |
|
TPSA |
37.30 |
Hetero Atoms |
2 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
271.6 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.89 |
LogP |
2.678 |
iLOGP |
2.17 |
XLOGP3 |
3.04 |
WLOGP |
2.68 |
MLOGP |
2.28 |
ESOL Log S |
-2.34 |
ESOL Solubility (mg/ml) |
0.723 |
ESOL Solubility (mol/l) |
0.005 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.49 |
Ali Solubility (mg/ml) |
0.05 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.09 |
Silicos-IT Solubility (mg/ml) |
1.29 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.11 |
Bioavailability Score |
0.85 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.731 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.927 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |